NFKB1 and cancer: These interactions are crucial for initiating IKK activation within cells, a prerequisite for NF-κB pathway activation.293–295 Impairments in NEMO’s phase separation capability due to mutations are associated with various human immunodeficiencies and cancers, primarily due to compromised NF-κB activation.